Latest Options News

Findi Ltd reports flat revenue and a 15% rise in EBITDA but swings to a $12.5 million net loss for FY2025, driven by strategic capital raises and refinancing in its Indian subsidiary.

Dimerix has activated the first clinical trial site in Japan for its pivotal Phase 3 ACTION3 study targeting FSGS, triggering a significant milestone payment from its Japanese partner FUSO Pharmaceutical.

RareX Limited has partnered with Gega Elements to develop Australia’s inaugural integrated gallium supply chain, aiming to reduce reliance on Chinese supply and boost national critical mineral resilience.

Rumble Resources updates its Western Queen Gold Project with a revised open pit mine plan that increases capital needs, explores underground mining, and eyes a new tungsten revenue stream.

Tennant Minerals has secured $550,000 through a share placement to fund exploration and development at its Barkly copper-gold project, including the promising Bluebird discovery.

Lord Resources Limited has announced a pro-rata non-renounceable entitlement issue to raise approximately $1.39 million, primarily to fund exploration at its Ilgarari Copper Project. The offer presents both opportunity and risk for shareholders amid ongoing funding needs and exploration uncertainties.

West Coast Silver has initiated a 1,500-metre diamond drilling campaign at its historically rich Elizabeth Hill Silver Project in Western Australia, aiming to unlock new high-grade mineralisation using modern exploration techniques.

Global X Management (AUS) Limited has announced updated estimated distributions for three ETFs listed on the ASX AQUA Market, providing investors with fresh income expectations ahead of the May 2025 period close.

Vintage Energy has successfully completed a $2.1 million capital raise through fully subscribed Entitlement and Shortfall Offers, aiming to enhance gas output from its Cooper Basin fields.

TruScreen Group Limited has announced a capital raising initiative involving Placement and Share Purchase Plan (SPP) Options, aiming to secure approximately NZ$3 million to fund strategic growth and working capital needs. The offer, subject to shareholder approval, includes up to 80.9 million Placement Options and 55.5 million SPP Options exercisable at A$0.02.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.